Related Pages Search for Clinical Trials NCI's PDQ® Cancer Clinical Trials Registry. Bone Cancer Home Page NCI's gateway for information about bone cancer.

1.  Denosumab Keeps Bones Strong during Prostate Cancer Treatment
(Posted: 10/28/2009) - Treatment with the monoclonal antibody denosumab increased bone mineral density (BMD) and reduced the risk of fractures in men who received a common treatment for prostate cancer that had not spread to other parts of the body, according to the results of a large, placebo-controlled clinical trial published in the August 20 New England Journal of Medicine.

2.  Experimental Drug for Osteosarcoma Improves Overall Survival
(Posted: 03/04/2008) - Patients with osteosarcoma who received the experimental drug mifamurtide (L-MTP-PE) along with chemotherapy fared better than patients who received chemotherapy alone, according to the Feb. 1, 2008, Journal of Clinical Oncology.

3.  Improved Survival for Those With Ewing Sarcoma
(Posted: 02/27/2003, Reviewed: 02/01/2005) - Addition of the drugs ifosfamide and etoposide to standard chemotherapy for Ewing sarcoma significantly improved five-year survival in patients whose disease had not spread to other organs, according to the February 20, 2003, issue of the New England Journal of Medicine.

4.  For Transplant Patients, Oral Antinausea Drug May Be Cheaper, Just as Effective
(Posted: 03/14/2002, Reviewed: 03/23/2005) - For patients receiving high-dose chemotherapy or radiation to prepare them for a bone marrow transplant (BMT), intravenous antiemetics have seemed better than oral agents at controlling nausea and vomiting. Now the results of a November 2001 study challenge this assumption.